Top Markets
Coin of the day
ProstaLund AB (publ) ProstaLund AB (publ)

ProstaLund AB (publ)

PLUN
Rank in Stocks #40781
ProstaLund AB (publ) specializes in the creation and distribution of urological... ProstaLund AB (publ) specializes in the creation and distribution of urological medical devices, primarily targeting patients with benign prostatic hyperplasia (BPH) in Sweden and across global markets. Their product offerings include CoreTherm, a thermal treatment method for BPH, and Gepan instill, designed for addressing chronic bladder inflammation. These solutions are utilized in hospitals and various clinical settings. Established in 1991, the company is based in Lund, Sweden, and operates as a subsidiary of Farstorps Gard Forvaltnings AB.
Share Price
$0.02256395
Last synced: 2025-11-03
Market Cap
$81.77K
Change (1 day)
-5.60%
Change (1 year)
-58.58%
Country
SE
Trade ProstaLund AB (publ) (PLUN)

Category

P/E ratio for ProstaLund AB (publ) (PLUN)
P/E ratio as of 2026 TTM: 0
According to ProstaLund AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for ProstaLund AB (publ) from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.